IM Cannabis (IMCC) Stock Soars 34% on European Drone Acquisition Plan

Key Points

• IMCC shares climbed approximately 34% following the announcement of a proposed defense technology acquisition.
• The company entered a non-binding LOI for a 51% stake in Space Defense Innovations.
• SDI focuses on tactical unmanned aircraft systems within the European market.
• Transaction terms include equity, warrants, seller financing and a credit facility up to €2.3 million.
• The agreement remains preliminary and requires due diligence completion and regulatory consent.

IM Cannabis (IMCC) shares experienced a significant rally of approximately 34% on Wednesday following the company’s disclosure of its intention to secure controlling interest in a European tactical drone enterprise. Prior to this announcement, IMCC concluded Tuesday’s trading session at $4.14.

IM Cannabis Corp., IMCC

The substantial price movement stems primarily from IM Cannabis’s planned purchase of a 51% ownership stake in Space Defense Innovations, commonly known as SDI. This strategic move would represent a dramatic pivot from the company’s core medical cannabis business toward defense and aerospace sectors.

Crucially, this remains a proposed transaction rather than a finalized deal. IM Cannabis has executed a non-binding letter of intent, meaning the acquisition must still clear several hurdles including comprehensive due diligence, final contract execution, regulatory clearances and additional closing requirements.

IMCC Pursues European Unmanned Aircraft Market

Space Defense Innovations operates as a Polish entity active in the unmanned aerial systems sector via its fully-owned BlueAero Group subsidiary. BlueAero serves as the European distributor for BlueBird Aero Systems’ tactical UAS products and hybrid fixed-wing VTOL platforms, holding exclusive distribution rights throughout Poland.

Additionally, SDI anticipates becoming a producer of these systems pending receipt of necessary regulatory authorizations. This manufacturing capability remains prospective at this stage and should not be considered an established, licensed operation.

According to the proposed arrangement, IM Cannabis would secure its 51% position in SDI through a combination of common shares and possibly pre-funded warrants. The deal structure also incorporates a 24-month seller financing component bearing 9% annual interest.

Warrants equivalent to 100% of the seller loan’s principal amount would be granted with an exercise price established at a 25% premium above IMCC’s share price at the time definitive contracts are executed. This framework introduces potential equity dilution for existing IMCC shareholders should these instruments be issued and subsequently exercised.

IM Cannabis has also committed to providing SDI with an on-demand credit facility totaling up to €2.3 million upon deal closure. This financing arrangement would reach maturity after 36 months and could be converted into SDI equity at IM Cannabis’s election.

The agreement would grant the company authority to designate a board majority at SDI. Additionally, IM Cannabis would obtain a five-year option to purchase the outstanding 49% stake using the same valuation methodology applied to the initial acquisition.

Substantial Price Rally Carries Transaction Uncertainty

This proposed deal constitutes a fundamental strategic transformation for a company whose entire market capitalization measures only several million dollars. IMCC’s modest size and restricted share float can amplify price volatility when significant corporate announcements emerge.

IM Cannabis has previously explored diversification beyond medical cannabis operations. Earlier this year, the company announced another non-binding LOI concerning Polish defense technology firm Blackaxe Technologies, though that arrangement was similarly characterized as an exploratory expansion into technology sectors.

This current proposal emerges as IM Cannabis concentrates its cannabis business primarily on the Israeli market while simultaneously pursuing alternative business ventures. Successful completion of the SDI transaction would provide the company with exposure to tactical unmanned systems and European defense expenditure.

Investors must also consider financing considerations. The proposed structure encompasses stock issuance, warrant grants, debt obligations and a €2.3 million credit commitment, all of which could strain a company with such limited market capitalization.

Execution uncertainty exists because SDI’s intended manufacturing operations depend upon securing regulatory licenses. The letter of intent itself remains subject to modification or cancellation, with no guarantee that binding agreements will ultimately materialize.

Currently, the proposed SDI transaction stands as the evident catalyst for IMCC’s dramatic price appreciation. The parties intend to finalize definitive agreements within a 60-day timeframe, establishing the next significant milestone as a binding transaction rather than Wednesday’s preliminary announcement.